Organogenesis Holdings Inc. (ORGO)

Organogenesis Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	384	540	352	1,189	812	456
Market Cap Growth	34.13%	53.35%	-70.37%	46.45%	78.10%	30.14%
Enterprise Value	411	555	373	1,206	812	496
PE Ratio	72.50	109.21	22.67	12.62	47.09	-11.60
PS Ratio	0.88	1.25	0.78	2.54	2.40	1.75
PB Ratio	1.38	1.94	1.33	4.93	5.72	8.20
P/FCF Ratio	56.47	82.41	-38.96	38.65	-66.46	-11.46
P/OCF Ratio	14.88	17.47	14.17	19.18	148.49	-13.59
EV/Sales Ratio	0.94	1.28	0.83	2.58	2.40	1.90
EV/EBITDA Ratio	11.27	15.41	9.24	13.87	21.80	-25.13
EV/EBIT Ratio	32.31	44.12	16.72	17.16	27.94	-16.78
EV/FCF Ratio	60.42	84.70	-41.23	39.22	-66.46	-12.47
Debt / Equity Ratio	0.42	0.43	0.47	0.55	0.60	1.81
Debt / EBITDA Ratio	3.18	3.31	3.07	1.52	2.28	-5.10
Debt / FCF Ratio	17.07	18.21	-13.70	4.30	-6.94	-2.53
Quick Ratio	2.24	2.31	2.57	2.38	2.08	1.67
Current Ratio	2.74	2.80	2.97	2.74	2.56	2.10
Asset Turnover	0.95	0.95	1.00	1.26	1.41	1.41
Interest Coverage	6.20	5.75	11.10	9.72	2.57	-3.29
Return on Equity (ROE)	2.10%	1.80%	6.10%	49.10%	24.30%	-126.50%
Return on Assets (ROA)	1.30%	1.10%	3.50%	25.30%	7.20%	-21.20%
Return on Capital (ROIC)	1.75%	1.50%	4.39%	28.86%	11.43%	-19.11%
Earnings Yield	1.51%	0.92%	4.41%	7.93%	2.12%	-8.62%
FCF Yield	1.77%	1.21%	-2.57%	2.59%	-1.50%	-8.73%
Buyback Yield / Dilution	-0.59%	-0.27%	0.96%	-20.03%	-19.95%	-33.93%
Total Shareholder Return	-0.59%	-0.27%	0.96%	-20.03%	-19.95%	-33.93%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).